In this task, you are given a summary for US Congressional and California state bill, your task is to generate a Title for this bill. The preferred titles are under forty words and mention the purpose of the bill.

Amends the Federal Food, Drug, and Cosmetic Act to require license applications for new drugs and biological products to assess such drug's or product's safety and effectiveness for relevant pediatric subpopulations, including dosage.Permits extrapolation from adult studies where the course of the disease and the effects of the drug are sufficiently similar in all populations.Permits deferral of such assessments if adult studies are completed earlier and the applicant submits a plan for or a description of planned or ongoing pediatric studies.Permits full waiver of such assessments if: (1) studies are highly impractical or impossible; (2) the evidence strongly suggests that the drug or product would be ineffective or unsafe in all pediatric age groups; (3) there is no meaningful therapeutic advantage or benefit in the pediatric population; or (4) the drug or product is not likely to be used in a substantial number of pediatric patients.Permits partial waivers at the request of an applicant for a specific pediatric subpopulation if any of the full waiver grounds apply to that subpopulation or reasonable attempts for a pediatric formulation for that subpopulation have failed.Requires labels to provide indication in cases in which a waiver has been granted due to evidence a product would be unsafe or ineffective in pediatric populations.Authorizes the Secretary of Health and Human Services to specify a date for submission of pediatric assessments if: (1) the drug or biological product would represent a meaningful therapeutic benefit for pediatric patients for one or more claimed indications and the absence of adequate labeling could pose significant risks to pediatric patients; or (2) it is used for a number of pediatric patients for the labeled indications and the absence of adequate labeling could pose significant risks to pediatric patients. Sets forth criteria for full waiver and partial waivers of such requirement. Requires labels to provide indication in cases in which a waiver has been granted due to evidence a product would be unsafe or ineffective in pediatric populations.Requires the Secretary to issue a written request for related pediatric studies under the Public Health Service Act before requiring an assessment for a drug.States that drugs or products with delayed assessments may be deemed misbranded and subject to seizure and injunctive proceedings, though not penalties.
To amend the Federal Food, Drug, and Cosmetic Act to require labeling containing information applicable to pediatric patients.

Coastal Services and Performance Evaluation Act of 2003 - Amends Federal law to make loan repayments deposited in the Coastal Zone Management Fund available to offset costs of implementing coastal zone management programs.Requires the Secretary of Commerce to provide training, education, and technical assistance for coastal zone management. Authorizes Federal agencies and instrumentalities to assist the Secretary on a reimbursable basis.Revises review requirements for coastal State management programs to change the frequency of review from continuing to every five years.Makes the Walter B. Jones Excellence in Coastal Zone Management Awards program discretionary instead of mandatory.Requires the Secretary to establish a national coastal zone management outcome indicators monitoring and performance evaluation system that provides for public comment and participation and uses a common set of measurable outcome indicators to evaluate the performance of State coastal zone management programs.
To amend the Coastal Zone Management Act of 1972 to reauthorize coastal services, training, education, and technical support programs of the National Oceanic and Atmospheric Administration, to establish a performance evaluation system for such administration, and for other purposes.

Support for Vulnerable and Displaced Iraqis Act of 2008 - Directs the Secretary of State to develop a comprehensive regional strategy to address the mass displacement of Iraqis inside Iraq and as refugees into neighboring countries.

Requires that such strategy: (1) address the challenges facing Iraqi refugees; (2) address the government of Iraq's responsibility to help meet the humanitarian needs of its citizens in Iraq and the region and related U.S. support; (3) assess the needs of vulnerable Iraqis in Iraq, especially internally displaced persons and Iraqi refugees in the region; (4) include the number of refugees from Iraq that the United States plans to resettle in the United States; (5) describe U.S. government steps to engage the international community and the government of Iraq in implementing such strategy; and (6) include plans to assess the strategy's impact.

A bill to address the ongoing humanitarian crisis in Iraq and potential security breakdown resulting from the mass displacement of Iraqis inside Iraq and as refugees into neighboring countries.